Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV):: in vitro and in vivo effects of genotoxic agents
Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV):: in vitro and in vivo effects of genotoxic agents
复制标题
DOI:
10.1016/s0168-8278(00)80102-6
复制
发表时间:
2000-06-01
影响因子:
25.7
通讯作者:
Prieto, J
中科院分区:
文献类型:
--
作者:
Peng, DC;Qian, C;Prieto, J
Background/Aims: Adeno-associated virus (AAV) is an attractive tool for gene therapy. Here we investigated the in vitro and in vivo transduction of hepatocellular carcinoma (HCC) cells by an AAV vector and the efficacy of different strategies to enhance the transduction of the tumor.Methods: Transduction efficiency was determined by analyzing AAV-mediated beta-galactosidase gene (rAAV/ lacZ) expression.Results: Adenovirus help or pretreatment of HCC cells with gamma-irradiation or with the topoisomerase inhibitor etoposide resulted in marked enhancement of cell transduction in vitro, In vivo studies in nude mice with subcutaneous HCC tumors showed that HCC cells were not transduced by AAV vector alone. However, co-infection of the tumor with adenovirus allowed an efficient expression of the reporter gene but only at the sites of vector injection. Previous gamma-irradiation of subcutaneous tumors with 1800 rad was able to improve transduction of HCC cells (up to 30%) using recombinant AAV Continuous i.p. infusion of etoposide in buffalo rats harboring HCC tumors in the liver resulted in transduction of normal liver tissue and also of very small neoplastic lesions (